Morning Market Movers
May 01, 2014 at 09:37 AM EDT
Merrimack Pharmaceuticals (NASDAQ: MACK) climbed 67.88% to $7.37 after the company reported that MM-398 has achieved primary endpoint of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.